Smartkarma AI, Smartkarma

αSK

Smartkarma AI

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
  <li>GSK is a global healthcare company with a strategic focus on vaccines and specialty medicines, particularly in infectious diseases, HIV, oncology, and immunology/respiratory therapeutic areas.</li>
  <li>The company has a robust pipeline with 20 vaccines and 42 medicines in development, many of which have the potential to be first-in-class or best-in-class treatments.</li>
  <li>Following the demerger of its Consumer Healthcare business, GSK is targeting sales of over £33 billion by 2031, driven by its late-stage pipeline assets which are projected to deliver peak annual sales of more than £20 billion.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  GSK is a global healthcare company with a strategic focus on vaccines and specialty medicines, particularly in infectious diseases, HIV, oncology, and immunology/respiratory therapeutic areas.
  The company has a robust pipeline with 20 vaccines and 42 medicines in development, many of which have the potential to be first-in-class or best-in-class treatments.
  Following the demerger of its Consumer Healthcare business, GSK is targeting sales of over £33 billion by 2031, driven by its late-stage pipeline assets which are projected to deliver peak annual sales of more than £20 billion.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: GlaxoSmithKline PLC (GSK LN) - Sep 2025

United Kingdom

GlaxoSmithKline PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Primer: GlaxoSmithKline PLC (GSK LN) - Sep 2025

GSK is a global healthcare company with a strategic focus on vaccines and specialty medicines, particularly in infectious diseases, HIV,...

αSK